AMEX Drug Stocks Alert: Neostem Inc, IsoRay, Protalix BioTherapeutics Inc, China Pharma Holdings

Lakeway, TX -- (SBWIRE) -- 03/08/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Neostem Inc.(NYSEAMEX:NBS) is higher 11.32% and is trading at $0.590. NeoStem, Inc. (NeoStem), is a international biopharmaceutical company. The Company operates in three segments: Cell Therapy-United States; Regenerative Medicine- China and Pharmaceutical Manufacturing-China. The Company is a provider of adult stem cell collection, processing and storage services in the United States, enabling healthy individuals to donate and store their stem cells for personal therapeutic use.

How Should Investors Trade NBS After The Recent Movement? Find Out Here

IsoRay, Inc.(NYSEAMEX:ISR) is higher 11.76% and is trading at $0.570. IsoRay, Inc. (IsoRay) develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association for treatment for all solid tumor applications using Cesium-131.

Is ISR Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Protalix BioTherapeutics Inc.(NYSEAMEX:PLX) moved up 0.53% and is trading at $5.71. Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action.

Is PLX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

China Pharma Holdings, Inc.(NYSEAMEX:CPHI) is higher 5.08% and is trading at $0.310. China Pharma Holdings, Inc. is engaged in the development, manufacture and marketing of pharmaceutical products for human uses in connection with a range of high-incidence and high-mortality diseases and medical conditions in the People's Republic of China (the PRC). All of the Company's operations are conducted in the PRC, where its manufacturing facilities are located.

How Should Investors Trade CPHI After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.